Singapore markets close in 6 hours 46 minutes

AN2 Therapeutics, Inc. (ANTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.2300-0.0400 (-1.76%)
At close: 04:00PM EDT
2.2300 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-66,026
-64,732
-40,956
-21,543
-13,603
Stock-based compensation
8,729
8,412
4,391
974
40
Change in working capital
1,489
5,834
3,718
32
1,224
Accounts payable
-1,113
553
2,497
417
81
Other working capital
-59,285
-53,288
-33,462
-20,484
-5,364
Other non-cash items
-
53
77
-
6,975
Net cash provided by operating activities
-59,285
-53,288
-33,462
-20,484
-5,364
Cash flows from investing activities
Purchases of investments
-118,165
-132,178
-93,836
-77,274
0
Sales/maturities of investments
90,290
88,900
72,065
27,250
0
Net cash used for investing activities
-27,875
-43,278
-21,771
-50,024
0
Cash flows from financing activities
Common stock issued
-
84,529
70,366
0
-
Other financing activities
-
-
-11
-1,210
-
Net cash used provided by (used for) financing activities
85,144
84,994
70,355
78,535
3,836
Net change in cash
-2,016
-11,572
15,122
8,027
-1,528
Cash at beginning of period
26,709
27,219
12,097
4,070
5,598
Cash at end of period
24,693
15,647
27,219
12,097
4,070
Free cash flow
Operating cash flow
-59,285
-53,288
-33,462
-20,484
-5,364
Free cash flow
-59,285
-53,288
-33,462
-20,484
-5,364